https://ift.tt/2IVHF6y

The stock slipped 11% to Rs 2,070 on the NSE after the drug maker said the preliminary injunction orders issued on Friday by a US court against the company on the launch of generic Suboxone.

from Markets https://ift.tt/2L09N9J

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads